Medical Marijuana, Inc.
245 articles about Medical Marijuana, Inc.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Joins U.S. Hemp Roundtable Board of Directors
10/22/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been selected as a member of the Board of Directors for the U.S. Hemp Roundtable.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Hemp for Humanity Educational Event Tour Throughout Japan
10/17/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is hosting a series of "Hemp for Humanity" events in Fukuoka, Osaka and Tokyo, Japan, this month.
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo
10/15/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division
10/10/2019
Medical Marijuana, Inc. announced that its subsidiary Kannaway® has launched a new website and back office available in Japanese catered to servicing the expansion into Japan and Asia.
-
Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards
10/8/2019
Medical Marijuana, Inc. announced that its subsidiary Kannaway® has earned two prestigious Golden Bridge Awards® -- including a Silver Award for Company of the Year in the Healthcare Products and Services category and the Company's CEO Blake Schroeder earned a Gold Award for International Executive of the Year in the Healthcare Products and Services category.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour
10/3/2019
Medical Marijuana, Inc. announced that its subsidiary Kannaway® is hosting a Road to Area Tour throughout Europe between Oct. 5-13.
-
Medical Marijuana, Inc. CEO to Speak at Hemp for the Future Event in Reykjavík, Iceland
10/1/2019
Medical Marijuana, Inc. announced that the Company's Chief Executive Officer Dr. Stuart Titus will be presenting at the Hemp for the Future educational event in Reykjavík, Iceland, on Oct. 1-2.
-
Medical Marijuana, Inc. Reaches One-Year Milestone in High-Level CBD Hemp Oil Stability Study
9/26/2019
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that the Company has reached a one-year milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™). The stability study was conducted in strict compliance with FDA/ICH guidelines (Q1A-R2).
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Presents at MJBizDaily Latin American Cannabis Symposium
9/24/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be a featured speaker at the MJBizDaily Latin American Cannabis Symposium in Bogotá, Columbia, on Sept. 30 – Oct. 1.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Super Academy Event and Product Launch in Amsterdam
9/19/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® is hosting a Super Academy event in Amsterdam on Sept. 27-29.
-
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
9/12/2019
Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its major investment company AXIM® Biotechnologies, Inc. ("AXIM® Biotech" or "AXIM") (OTCQB: AXIM) has begun manufacturing its cannabinoid-based chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC).
-
HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Presence at Natural Products Expo East
9/10/2019
Medical Marijuana, Inc. announced that its subsidiary HempMeds® will be attending and exhibiting at Natural Products Expo East in Baltimore, Maryland, on Sept. 11-14.
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hires Gabriel Barbosa as Scientific Projects and Regulatory Developing Analyst
9/5/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil has hired Gabriel Barbosa, MSc as the Company's Scientific Projects and Regulatory Developing Analyst.
-
Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics
8/22/2019
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that equity research firm Avise Analytics, Ltd. ("Avise Analytics") ranked the Company as one of the Top 5 Companies in the Hemp-Based Cannabidiol (CBD) Market.
-
Medical Marijuana, Inc. Reports $20.7 Million in Revenue in Q2 2019, Up 30% Year-Over-Year in Financial Results
8/15/2019
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today its financial results for the quarter ending June 30, 2019, and provided an overview of recent operational highlights.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products
8/1/2019
Kannaway® and Endocanna will collaborate on the development and distribution of endocannabinoid DNA test products.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy and Website to Expand Consumer Reach
7/11/2019
Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products.
-
Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Announce June 2019 as the Largest Sales Bookings Month in Company History
7/9/2019
Medical Marijuana, Inc. announced that the company and its subsidiaries Kannaway® and HempMeds® had their largest-ever (unaudited) sales bookings month in the Company's history in June 2019.
-
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner
6/26/2019
Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that products from the Company's major investment company AXIM® Biotechnologies, Inc.
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo
6/18/2019
Medical Marijuana, Inc. announced that its subsidiary HempMeds® Brasil is hosting its third series of doctors' courses on cannabinoids and CBD at the HempMeds® Brasil headquarters in São Paulo on Monday, June 24, and Friday, June 28.